WinfredC.WangMD

Professor of Pediatrics, University Tenn College of Medicine

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
262 Danny Thomas Pl
Memphis, TN 38105
Phone+1 901-595-3497

Fax+1 901-595-3842

University of California (San Francisco)Residency, Pediatrics, 1974 - 1974
University of California (San Francisco)Residency, Internal Medicine, 1972 - 1973
University of HawaiiResidency, Pediatrics, 1969 - 1970
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1967 - 1969
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1967

PubMed

540 citations
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
Winfred C. Wang, Russell E. Ware, Scott T. Miller, Rathi V. Iyer, James F. Casella
Lancet. 2011-05-14
288 citations
R2* magnetic resonance imaging of the liver in patients with iron overload
Jane S. Hankins, M. Beth McCarville, Ralf B. Loeffler, Matthew P. Smeltzer, Mihaela Onciu
Blood. 2009-05-14
223 citations
Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease.
Winfred C. Wang, Laura E. Enos, Dianne Gallagher, Robert J. Thompson, Ludovico Guarini
The Journal of Pediatrics. 2001-09-01

Abstracts/Posters

Neurocognitive Impairment Predicts Poor Transition Outcomes Among Patients with Sickle Cell Disease
Winfred Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Transcranial Doppler Velocities Conversion Rate Based on Increasing Hemoglobin Concentration: Analysis from the SCCRIP Cohort Study
Winfred Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Progression of Central Nervous System Vasculopathy in Young Adults with Sickle Cell Anemia
Winfred Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

2017 American Society of Hematology (ASH) MeetingDecember 11th, 2018
Sickle Cell Anemia Drug Safe and Effective for Infants and Toddlers, Adds Treatment Option, Study SuggestsJune 14th, 2011
Drug Treatment Means Better, Less Costly Care for Children with Sickle Cell DiseaseFebruary 10th, 2016
Join now to see all

Treatment With Hydroxyurea And Magnesium:A Prospective Phase III Clinical TrialNational Heart, Lung, And Blood Institute2004–2007
Sickle Cell Scholar'S ProgramNational Heart, Lung, And Blood Institute2003–2007
Comprehensive Sickle Cell CenterNational Heart, Lung, And Blood Institute2003–2007
Combination Treatment With Hydroxyurea And Magnesium: Phase I &Phase II StudiesNational Heart, Lung, And Blood Institute2003–2007
Combination Treatment With Hydroxyurea And Magnesium:A Prospective Randomized DouNational Heart, Lung, And Blood Institute2003
Administrative CoreNational Heart, Lung, And Blood Institute2003
Pedriatric Hydroxyurea Phase III Clinical Trial ClinicalDivision Of Blood Diseases And Resources2000–2001
Pediatric Cohort Of The CsscdDivision Of Blood Diseases And Resources1994–1998
Selected Patient Groups From The CsscdDivision Of Blood Diseases And Resources1994
Investigation Of Selected Patient Groups From The CsscdDivision Of Blood Diseases And Resources1989–1993
Prophylactic Penicillin In Sickle Cell DiseaseDivision Of Blood Diseases And Resources1987–1993